Knight Therapeutics (OTCMKTS:KHTRF) Shares Up 1.7% – Should You Buy?

Knight Therapeutics Inc. (OTCMKTS:KHTRF) shares shot up 1.7% during trading on Friday . The company traded as high as $5.50 and last traded at $5.50. 5,600 shares were traded during mid-day trading, an increase of 28% from the average session volume of 4,375 shares. The stock had previously closed at $5.41.

Knight Therapeutics Price Performance

The stock has a 50 day moving average of $4.95 and a 200 day moving average of $4.51.

Knight Therapeutics Company Profile

Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.

Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.